TY - JOUR
T1 - Relaxing Responses to Hydrogen Peroxide and Nitric Oxide in Human Pericardial Resistance Arteries Stimulated with Endothelin-1
AU - Leurgans, Thomas M
AU - Bloksgaard, Maria
AU - Irmukhamedov, Akhmadjon
AU - Riber, Lars P.
AU - De Mey, Jo G R
N1 - This article is protected by copyright. All rights reserved.
PY - 2018/1
Y1 - 2018/1
N2 - In human pericardial resistance arteries, effects of the endothelium-dependent vasodilator bradykinin are mediated by NO during contraction induced by K
+ or the TxA
2 analogue U46619 and by H
2O
2 during contraction by endothelin-1 (ET-1), respectively. We tested the hypotheses that ET-1 reduces relaxing effects of NO and increases those of H
2O
2 in resistance artery smooth muscle of patients with cardiovascular disease. Arterial segments, dissected from the parietal pericardium of 39 cardiothoracic surgery patients, were studied by myography during amplitude-matched contractions induced by K
+, the TXA
2 analogue U46619 or ET-1. Effects of the NO donor Na-nitroprusside (SNP) and of exogenous H
2O
2 were recorded in the absence and presence of inhibitors of cyclooxygenases, NO synthases and small and intermediate conductance calcium-activated K
+ channels. During contractions induced by either of the three stimuli, the potency of SNP did not differ and was not modified by the inhibitors. In vessels contracted with ET-1, the potency of H
2O
2 was on average and in terms of interindividual variability considerably larger than in K
+-contracted vessels. Both differences were not statistically significant in the presence of inhibitors of mechanisms of endothelium-dependent vasodilatation. In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H
2O
2. Furthermore, the candidate endothelium-derived relaxing factor H
2O
2 also acts as an endothelium-dependent vasodilator.
AB - In human pericardial resistance arteries, effects of the endothelium-dependent vasodilator bradykinin are mediated by NO during contraction induced by K
+ or the TxA
2 analogue U46619 and by H
2O
2 during contraction by endothelin-1 (ET-1), respectively. We tested the hypotheses that ET-1 reduces relaxing effects of NO and increases those of H
2O
2 in resistance artery smooth muscle of patients with cardiovascular disease. Arterial segments, dissected from the parietal pericardium of 39 cardiothoracic surgery patients, were studied by myography during amplitude-matched contractions induced by K
+, the TXA
2 analogue U46619 or ET-1. Effects of the NO donor Na-nitroprusside (SNP) and of exogenous H
2O
2 were recorded in the absence and presence of inhibitors of cyclooxygenases, NO synthases and small and intermediate conductance calcium-activated K
+ channels. During contractions induced by either of the three stimuli, the potency of SNP did not differ and was not modified by the inhibitors. In vessels contracted with ET-1, the potency of H
2O
2 was on average and in terms of interindividual variability considerably larger than in K
+-contracted vessels. Both differences were not statistically significant in the presence of inhibitors of mechanisms of endothelium-dependent vasodilatation. In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H
2O
2. Furthermore, the candidate endothelium-derived relaxing factor H
2O
2 also acts as an endothelium-dependent vasodilator.
KW - Aged
KW - Cardiovascular Diseases/physiopathology
KW - Coronary Vessels/drug effects
KW - Endothelin-1/metabolism
KW - Endothelium, Vascular/drug effects
KW - Female
KW - Humans
KW - Hydrogen Peroxide/pharmacology
KW - Male
KW - Muscle, Smooth, Vascular/drug effects
KW - Nitric Oxide/pharmacology
KW - Nitroprusside/pharmacology
KW - Pericardium/physiopathology
KW - Vasodilation/drug effects
KW - Vasodilator Agents/pharmacology
U2 - 10.1111/bcpt.12843
DO - 10.1111/bcpt.12843
M3 - Journal article
C2 - 28686356
SN - 1742-7835
VL - 122
SP - 74
EP - 81
JO - Basic & Clinical Pharmacology & Toxicology
JF - Basic & Clinical Pharmacology & Toxicology
IS - 1
ER -